Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting.
Saved in:
| Title: | Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting. |
|---|---|
| Authors: | Sprecher A; Médecins Sans Frontières, Brussels, Belgium., Cross R; Galveston National Laboratory, University of Texas Medical Branch, Galveston., Marzi A; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana., Martins KA; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia., Wolfe D; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia., Montgomery JM; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Spiropoulou CF; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia., Cihlar T; Gilead Sciences Inc, Foster City, California., Ahuka-Mundeke S; Institut National de Recherche Biomédicale, Kinshasa, Republic of the Congo.; Kinshasa Teaching Hospital, School of Medicine, Kinshasa University, Democratic Republic of the Congo., Nyhuis T; Mapp Biopharmaceutical, Inc, San Diego, California., Teicher C; Médecins Sans Frontières, New York, New York., Crozier I; Clinical Monitoring Program Research Directorate, Frederick National Laboratory for Cancer Research, Maryland., Strong J; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg.; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg., Kobinger G; Galveston National Laboratory, University of Texas Medical Branch, Galveston., Woolsey C; Galveston National Laboratory, University of Texas Medical Branch, Galveston., Geisbert TW; Galveston National Laboratory, University of Texas Medical Branch, Galveston., Feldmann H; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana., Muyembe JJ; Institut National de Recherche Biomédicale, Kinshasa, Republic of the Congo.; Kinshasa Teaching Hospital, School of Medicine, Kinshasa University, Democratic Republic of the Congo. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2023 Nov 13; Vol. 228 (Suppl 7), pp. S474-S478. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37596837 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Sprecher+A%22">Sprecher A</searchLink>; Médecins Sans Frontières, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Cross+R%22">Cross R</searchLink>; Galveston National Laboratory, University of Texas Medical Branch, Galveston.<br /><searchLink fieldCode="AU" term="%22Marzi+A%22">Marzi A</searchLink>; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.<br /><searchLink fieldCode="AU" term="%22Martins+KA%22">Martins KA</searchLink>; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Wolfe+D%22">Wolfe D</searchLink>; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Health and Human Services, Washington, District of Columbia.<br /><searchLink fieldCode="AU" term="%22Montgomery+JM%22">Montgomery JM</searchLink>; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Spiropoulou+CF%22">Spiropoulou CF</searchLink>; Viral Special Pathogens Branch, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.<br /><searchLink fieldCode="AU" term="%22Cihlar+T%22">Cihlar T</searchLink>; Gilead Sciences Inc, Foster City, California.<br /><searchLink fieldCode="AU" term="%22Ahuka-Mundeke+S%22">Ahuka-Mundeke S</searchLink>; Institut National de Recherche Biomédicale, Kinshasa, Republic of the Congo.; Kinshasa Teaching Hospital, School of Medicine, Kinshasa University, Democratic Republic of the Congo.<br /><searchLink fieldCode="AU" term="%22Nyhuis+T%22">Nyhuis T</searchLink>; Mapp Biopharmaceutical, Inc, San Diego, California.<br /><searchLink fieldCode="AU" term="%22Teicher+C%22">Teicher C</searchLink>; Médecins Sans Frontières, New York, New York.<br /><searchLink fieldCode="AU" term="%22Crozier+I%22">Crozier I</searchLink>; Clinical Monitoring Program Research Directorate, Frederick National Laboratory for Cancer Research, Maryland.<br /><searchLink fieldCode="AU" term="%22Strong+J%22">Strong J</searchLink>; Special Pathogens Program, National Microbiology Laboratory Branch, Public Health Agency of Canada.; Department of Medical Microbiology and Infectious Diseases, University of Manitoba, Winnipeg.; Department of Pediatrics and Child Health, University of Manitoba, Winnipeg.<br /><searchLink fieldCode="AU" term="%22Kobinger+G%22">Kobinger G</searchLink>; Galveston National Laboratory, University of Texas Medical Branch, Galveston.<br /><searchLink fieldCode="AU" term="%22Woolsey+C%22">Woolsey C</searchLink>; Galveston National Laboratory, University of Texas Medical Branch, Galveston.<br /><searchLink fieldCode="AU" term="%22Geisbert+TW%22">Geisbert TW</searchLink>; Galveston National Laboratory, University of Texas Medical Branch, Galveston.<br /><searchLink fieldCode="AU" term="%22Feldmann+H%22">Feldmann H</searchLink>; Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.<br /><searchLink fieldCode="AU" term="%22Muyembe+JJ%22">Muyembe JJ</searchLink>; Institut National de Recherche Biomédicale, Kinshasa, Republic of the Congo.; Kinshasa Teaching Hospital, School of Medicine, Kinshasa University, Democratic Republic of the Congo. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220413675%22">The Journal of infectious diseases</searchLink> [J Infect Dis] 2023 Nov 13; Vol. 228 (Suppl 7), pp. S474-S478. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, N.I.H., Extramural – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0413675 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1537-6613 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200221899%22">00221899 </searchLink><i>NLM ISO Abbreviation: </i>J Infect Dis <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37596837 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/infdis/jiad354 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: S474 Titles: – TitleFull: Perspectives on Advancing Countermeasures for Filovirus Disease: Report From a Multisector Meeting. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Sprecher A – PersonEntity: Name: NameFull: Cross R – PersonEntity: Name: NameFull: Marzi A – PersonEntity: Name: NameFull: Martins KA – PersonEntity: Name: NameFull: Wolfe D – PersonEntity: Name: NameFull: Montgomery JM – PersonEntity: Name: NameFull: Spiropoulou CF – PersonEntity: Name: NameFull: Cihlar T – PersonEntity: Name: NameFull: Ahuka-Mundeke S – PersonEntity: Name: NameFull: Nyhuis T – PersonEntity: Name: NameFull: Teicher C – PersonEntity: Name: NameFull: Crozier I – PersonEntity: Name: NameFull: Strong J – PersonEntity: Name: NameFull: Kobinger G – PersonEntity: Name: NameFull: Woolsey C – PersonEntity: Name: NameFull: Geisbert TW – PersonEntity: Name: NameFull: Feldmann H – PersonEntity: Name: NameFull: Muyembe JJ IsPartOfRelationships: – BibEntity: Dates: – D: 13 M: 11 Text: 2023 Nov 13 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1537-6613 Numbering: – Type: volume Value: 228 – Type: issue Value: Suppl 7 Titles: – TitleFull: The Journal of infectious diseases Type: main |
| ResultId | 1 |